Phase II feasibility study of preoperative chemotherapy with docetaxel, cisplatin, and fluorouracil for esophageal squamous cell carcinoma

Hara, Hiroki; Tahara, Makoto; Daiko, Hiroyuki; Kato, Ken; Igaki, Hiroyasu; Kadowaki, Shigenori; Tanaka, Yoïchi; Hamamoto, Yasuo; Matsushita, Hisayuki; Nagase, Michitaka; Hosoya, Yoshinori

doi:10.1111/cas.12274

Public

Phase II feasibility study of preoperative chemotherapy with docetaxel, cisplatin, and fluorouracil for esophageal squamous cell carcinoma

Published in Cancer Science • Aug 30, 2013

Authors:

Hiroki Hara

Makoto Tahara

Hiroyuki Daiko

Abstract

The combination of docetaxel, cisplatin, and 5-fluorouracil (DCF) as preoperative treatment for esophageal squamous cell carcinoma (ESCC) has not been investigated. We carried out a multicenter phase II feasibility study of preoperative chemotherapy with DCF for ESCC. Patients with clinical stage II...

Subject

Docetaxel

Medicine

Esophagectomy

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!